| Sarah Katherine Brown, ANP | |
|
7200 S Hazel St, Pine Bluff, AR 71603-7836 | |
| (870) 534-2900 | |
| (870) 534-9726 |
| Full Name | Sarah Katherine Brown |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 7200 S Hazel St, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205009818 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | A03095 ANP (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Arkansas Cardiology, P.l.l.c. | 2264699479 | 5 |
News Archive
Researchers from Canada, South Africa and Italy have identified a new gene that can lead to sudden death among young people and athletes.
Immtech International has announced that all 30 patients participating in the concluded Phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness cleared the parasite that causes African sleeping sickness within the treatment period, with no significant adverse results reported.
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.
U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).
› Verified 3 days ago
| Entity Name | South Arkansas Cardiology, P.l.l.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568567188 PECOS PAC ID: 2264699479 Enrollment ID: O20120131000149 |
News Archive
Researchers from Canada, South Africa and Italy have identified a new gene that can lead to sudden death among young people and athletes.
Immtech International has announced that all 30 patients participating in the concluded Phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness cleared the parasite that causes African sleeping sickness within the treatment period, with no significant adverse results reported.
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.
U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).
› Verified 3 days ago
| Entity Name | Sark Opl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558893776 PECOS PAC ID: 7810261088 Enrollment ID: O20170927000871 |
News Archive
Researchers from Canada, South Africa and Italy have identified a new gene that can lead to sudden death among young people and athletes.
Immtech International has announced that all 30 patients participating in the concluded Phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness cleared the parasite that causes African sleeping sickness within the treatment period, with no significant adverse results reported.
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.
U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Katherine Brown, ANP Po Box 986, Pine Bluff, AR 71613-0986 Ph: (870) 534-2900 | Sarah Katherine Brown, ANP 7200 S Hazel St, Pine Bluff, AR 71603-7836 Ph: (870) 534-2900 |
News Archive
Researchers from Canada, South Africa and Italy have identified a new gene that can lead to sudden death among young people and athletes.
Immtech International has announced that all 30 patients participating in the concluded Phase IIb extended dose regimen arm of its clinical trial of DB289 for treating African sleeping sickness cleared the parasite that causes African sleeping sickness within the treatment period, with no significant adverse results reported.
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.
Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.
U.S. Ambassador Michael Ranneberger on Wednesday announced the U.S. would provide $26.5 million (2.7 billion Kenyan shillings) between 2009 and 2013 to fight HIV/AIDS in Kenya, the Daily Nation reports (Sinundu, 12/16). In related news, the Standard reports the Kenyan government will be begin the gradual phase out of the antiretroviral drug, Stavudine, which is known to cause adverse side effects (Mwai, 12/15).
› Verified 3 days ago
Mrs. Diana Gray Millenbaugh, MSN, RNP, BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3801 Camden Rd Ste 12, Pine Bluff, AR 71603 Phone: 870-534-4847 Fax: 870-534-4884 | |
Mrs. Lillian Jynes, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 209 N Blake St, Pine Bluff, AR 71601 Phone: 870-536-6600 | |
Dr. Michelle Leigh Bagby, DNP, FNP-C, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1101 S Tennessee St, Pine Bluff, AR 71601 Phone: 705-432-3808 Fax: 870-543-2368 | |
Collene Rogers, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1609 W 40th Ave Ste 205, Pine Bluff, AR 71603 Phone: 870-541-7211 | |
Ms. Ernice Lashette Rogers, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2306 Rike Dr, Pine Bluff, AR 71603 Phone: 870-535-2142 | |
Cornelia Rhodes, APRN-CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2410 W 24th Ave, Pine Bluff, AR 71603 Phone: 870-267-4912 | |
Shanda Vinson, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1515 W 42nd Ave, Pine Bluff, AR 71603 Phone: 870-541-6400 |